{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "NCT05348772",
            "NStudiesAvail": 430108,
            "NStudiesFound": 1,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 1,
            "FieldList": [
                  "ResultsFirstSubmitDate",
                  "ResultsFirstSubmitQCDate",
                  "RetractionPMID",
                  "RetractionSource",
                  "SamplingMethod",
                  "SecondaryId",
                  "SecondaryIdDomain",
                  "SecondaryIdLink",
                  "SecondaryIdType",
                  "SecondaryOutcomeDescription",
                  "SecondaryOutcomeMeasure",
                  "SecondaryOutcomeTimeFrame",
                  "SeeAlsoLinkLabel",
                  "SeeAlsoLinkURL",
                  "SeriousEventAssessmentType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Overall survival defined as time from ATIMP infusion to death for any cause",
                              "Event-free survival (defined as time from ATIMP infusion to \"event\" or death)",
                              "Ventilator-free days defined as days alive and free from mechanical ventilation",
                              "Time to clinical response defined as time from ATIMP infusion to improvement of at least 1 point in the National Institute of Allergy and Infectious Diseases (NIAID) 8-point ordinal scale for COVID-19 severity",
                              "Overall survival defined as time from ATIMP infusion to death for any cause",
                              "Time to hospital discharge defined as time from ATIMP infusion to time to hospital discharge"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "OS",
                              "Event-free survival",
                              "Ventilator-free days",
                              "Time to clinical response",
                              "OS",
                              "Time to hospital discharge"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "Day 22",
                              "Day 22",
                              "Day 22",
                              "Day 22",
                              "1 year",
                              "Day 22"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT05348772"
                        ]
                  }
            ]
      }
}